Warning: The NCBI web site requires JavaScript to function. more...
Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
George-Chandy A, Trysberg E, Eriksson K.
Arthritis Res Ther. 2008;10(4):R97. Epub 2008 Aug 22.
Related citations
Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
Hopia L, Thangarajh M, Khademi M, Laveskog A, Wallström E, Svenungsson E, Andersson M.
Scand J Rheumatol. 2011;40(5):363-72. Epub 2011 May 18.
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
Vallerskog T, Heimbürger M, Gunnarsson I, Zhou W, Wahren-Herlenius M, Trollmo C, Malmström V.
Arthritis Res Ther. 2006;8(6):R167.
The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
Jönsen A, Bengtsson AA, Nived O, Ryberg B, Truedsson L, Rönnblom L, Alm GV, Sturfelt G.
Lupus. 2003;12(11):846-50.
Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement.
Trysberg E, Carlsten H, Tarkowski A.
Lupus. 2000;9(7):498-503.
Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.
Arthritis Rheum. 2009 Jul;60(7):2094-101.
Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
Morel J, Roubille C, Planelles L, Rocha C, Fernandez L, Lukas C, Hahne M, Combe B.
Ann Rheum Dis. 2009 Jun;68(6):997-1002. Epub 2008 Aug 2.
Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.
Zhao LD, Li Y, Smith MF Jr, Wang JS, Zhang W, Tang FL, Tian XP, Wang HY, Zhang FC, Ba DN, He W, Zhang X.
Lupus. 2010 Nov;19(13):1534-49.
Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
Arthritis Rheum. 2005 Jun;52(6):1670-5.
Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, Sánchez-Guerrero J.
PLoS One. 2008 Oct 6;3(10):e3347.
Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
Matsushita T, Fujimoto M, Hasegawa M, Tanaka C, Kumada S, Ogawa F, Takehara K, Sato S.
J Rheumatol. 2007 Oct;34(10):2056-62. Epub 2007 Sep 15.
Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T, Hirata D, Onda K, Nara H, Minota S.
J Rheumatol. 2005 Jan;32(1):34-9.
Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
Matsushita T, Fujimoto M, Echigo T, Matsushita Y, Shimada Y, Hasegawa M, Takehara K, Sato S.
Exp Dermatol. 2008 Mar;17(3):197-202. Epub 2007 Nov 2.
Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Llorente L, Sánchez-Guerrero J.
Arthritis Rheum. 2007 Apr;56(4):1242-50.
Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus.
Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza LR.
Clin Rheumatol. 1998;17(2):110-4.
Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients.
Lin Z, Dan-Rong Y, Xiao-Qing T, Hao W, Hong-Lian G, Xian-Tao K, Ren-Qian Z, Jiyu L.
J Clin Lab Anal. 2007;21(3):183-7.
Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Trysberg E, Blennow K, Zachrisson O, Tarkowski A.
Arthritis Res Ther. 2004;6(6):R551-6. Epub 2004 Sep 23.
Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Fühlhuber V, Bick S, Kirsten A, Hahn A, Gerriets T, Tschernatsch M, Kaps M, Preissner KT, Blaes F, Altenkämper S.
J Neuroimmunol. 2009 May 29;210(1-2):87-91. Epub 2009 Mar 31.
Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
Trysberg E, Nylen K, Rosengren LE, Tarkowski A.
Arthritis Rheum. 2003 Oct;48(10):2881-7.
Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement.
Hirohata S, Miyamoto T.
Arthritis Rheum. 1990 May;33(5):644-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on